Investor Relations
Sep 14, 2018
OPKO Confirms Resumption of Common Stock Trading on Nasdaq MORE >>
Sep 11, 2018
OPKO Comments on Continued Nasdaq Halt of Trading of Common Stock MORE >>
Sep 07, 2018
OPKO Comments on SEC Complaint MORE >>
Sep 04, 2018
OPKO Initiates RAYALDEE Phase 2 Trial in Dialysis Patients MORE >>

SEC Filings

Form Description Filing date View
10-K

Annual report which provides a comprehensive overview of the company for the past year

View HTML
10-K

Annual report which provides a comprehensive overview of the company for the past year

View HTML
10-K

Annual report which provides a comprehensive overview of the company for the past year

View HTML
10-K

Annual report which provides a comprehensive overview of the company for the past year

View HTML
10-K

Annual report which provides a comprehensive overview of the company for the past year

View HTML
10-K

Annual report which provides a comprehensive overview of the company for the past year

View HTML
10-K

Annual report which provides a comprehensive overview of the company for the past year

View HTML
10-K

Annual report which provides a comprehensive overview of the company for the past year

View HTML
10-K

Annual report which provides a comprehensive overview of the company for the past year

View HTML
10-K

Annual report which provides a comprehensive overview of the company for the past year

View HTML EX-101.INS - XBRL INSTANCE DOCUMENT